• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·France·Technology·MEMS.PA
Share

MEMSCAP, S.A. Stocks

€ 4.51Last Updated 23.10.2026

Issuer Rating

4/7
Performance

Favourable

Risk

Considerable

Recommendation

Hold

Market Cap

€ 38.91M

€ 4.51
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Memscap, S.A. is a Crolles, France-based company, founded in 1997, that develops and delivers advanced micro-electro-mechanical systems (MEMS) solutions. Catering to a global clientele, the company serves diverse sectors including aerospace and defense, optical communication, medical and biomedical, and information technology/consumer electronics. Their extensive product catalog includes a variety of pressure sensing devices, such as sensors, transducers, and switches. These are crucial for applications ranging from air data computers, cabin pressure management, and engine control systems to altimeters, barometers, and cockpit instrumentation, as well as air data test sets. Additionally, they supply specialized gold-coated and titanium-based pressure transducers, along with accessories like plastic domes and line-sets, and offer magnetic switches/relays. In the medical domain, Memscap manufactures implantable pressure sensors vital for monitoring conditions like spinal pressure and abdominal aortic aneurysms. For the optical telecommunications industry, the company supplies optical MEMS chips integral to variable optical attenuators. Beyond products, Memscap offers a comprehensive suite of multi-user MEMS processes (MUMPs), including PolyMUMPs, SOIMUMPs, and PiezoMUMPs, complemented by MUMPs-PLUS and various post-processing services. They also cater to specific client needs through custom products, encompassing wafers, MEMS dies, and wafer-level packaged devices, alongside providing full manufacturing and prototyping services. Memscap's clientele spans Fortune 500 corporations, leading high-technology enterprises, esteemed research institutions, and academic universities.

Company Valuation

Fairly valued
4/7

Considering past and projected metrics, the stock is neither 'expensive' nor 'cheap' compared to its peers. Specifically, the stock is fairly valued on P/E, neutral on EV

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of MEMS.PA is 7.20 and suggests 59.6% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

24.10.2026 16:01

Highlights in Small-Cap Stocks: The Merck Deal, the Success of a Hair Loss Pill, and Braze's "Wow Factor"

24.10.2026 13:01

AI investors are already on the brink, a “French kiss” for the euro, and hackers at the gates

24.10.2026 05:04

Hedge funds have ramped up their bets against the euro to a 2020 high

24.10.2026 04:46

France Avoided a Downgrade by Moody’s After a Week of Crisis

24.10.2026 04:37

A key Novartis drug failed to meet expectations. The stock price fell

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026